Bumpers HL - Search Results

1

Predictive capacity of three comorbidity indices in estimating mortality after surgery for colon cancer.

Hines RB, Chatla C, Bumpers HL, Waterbor JW, McGwin G Jr, Funkhouser E, Coffey CS, Posey J, Manne U. Hines RB, et al. Among authors: bumpers hl. J Clin Oncol. 2009 Sep 10;27(26):4339-45. doi: 10.1200/JCO.2009.22.4758. Epub 2009 Aug 3. J Clin Oncol. 2009. PMID: 19652054 Free PMC article.

2

Evaluation of lymph node numbers for adequate staging of Stage II and III colon cancer.

Shanmugam C, Hines RB, Jhala NC, Katkoori VR, Zhang B, Posey JA Jr, Bumpers HL, Grizzle WE, Eltoum IE, Siegal GP, Manne U. Shanmugam C, et al. Among authors: bumpers hl. J Hematol Oncol. 2011 May 28;4:25. doi: 10.1186/1756-8722-4-25. J Hematol Oncol. 2011. PMID: 21619690 Free PMC article.

3

Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma.

Katkoori VR, Jia X, Shanmugam C, Wan W, Meleth S, Bumpers H, Grizzle WE, Manne U. Katkoori VR, et al. Clin Cancer Res. 2009 Apr 1;15(7):2406-16. doi: 10.1158/1078-0432.CCR-08-1719. Clin Cancer Res. 2009. PMID: 19339276 Free PMC article.

4

Bax expression is a candidate prognostic and predictive marker of colorectal cancer.

Katkoori VR, Suarez-Cuervo C, Shanmugam C, Jhala NC, Callens T, Messiaen L, Posey J 3rd, Bumpers HL, Meleth S, Grizzle WE, Manne U. Katkoori VR, et al. Among authors: bumpers hl. J Gastrointest Oncol. 2010 Dec;1(2):76-89. doi: 10.3978/j.issn.2078-6891.2010.019. J Gastrointest Oncol. 2010. PMID: 22811811 Free PMC article.

5

Development and progression of colorectal neoplasia.

Manne U, Shanmugam C, Katkoori VR, Bumpers HL, Grizzle WE. Manne U, et al. Among authors: bumpers hl. Cancer Biomark. 2010;9(1-6):235-65. doi: 10.3233/CBM-2011-0160. Cancer Biomark. 2010. PMID: 22112479 Free PMC article. Review.

6

miRNAs as biomarkers for management of patients with colorectal cancer.

Manne U, Shanmugam C, Bovell L, Katkoori VR, Bumpers HL. Manne U, et al. Among authors: bumpers hl. Biomark Med. 2010 Oct;4(5):761-70. doi: 10.2217/bmm.10.87. Biomark Med. 2010. PMID: 20945991 Free PMC article. Review.

7

Nef-M1, a CXCR4 Peptide Antagonist, Enhances Apoptosis and Inhibits Primary Tumor Growth and Metastasis in Breast Cancer.

Bumpers H, Huang MB, Katkoori V, Manne U, Bond V. Bumpers H, et al. J Cancer Ther. 2013 Jun;4(4):898-906. doi: 10.4236/jct.2013.44101. J Cancer Ther. 2013. PMID: 25285238 Free PMC article.

8

Nanomagnetic levitation three-dimensional cultures of breast and colorectal cancers.

Bumpers HL, Janagama DG, Manne U, Basson MD, Katkoori V. Bumpers HL, et al. J Surg Res. 2015 Apr;194(2):319-326. doi: 10.1016/j.jss.2014.12.036. Epub 2014 Dec 23. J Surg Res. 2015. PMID: 25617973 Free PMC article.

9

Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.

Katkoori VR, Basson MD, Bond VC, Manne U, Bumpers HL. Katkoori VR, et al. Among authors: bumpers hl. Oncotarget. 2015 Sep 29;6(29):27763-77. doi: 10.18632/oncotarget.4615. Oncotarget. 2015. PMID: 26318034 Free PMC article.

10

Functional consequence of the p53 codon 72 polymorphism in colorectal cancer.

Katkoori VR, Manne U, Chaturvedi LS, Basson MD, Haan P, Coffey D, Bumpers HL. Katkoori VR, et al. Among authors: bumpers hl. Oncotarget. 2017 Aug 29;8(44):76574-76586. doi: 10.18632/oncotarget.20580. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100333 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters